FH and renal cell carcinoma: Patients with hereditary leiomyomatosis and RCC (HLRCC) have a mutation in the gene encoding the Krebs cycle enzyme fumarate hydratase (FH), and are at risk of developing cutaneous and uterine leiomyomas and an aggressive phenotype of type 2 pRCC [45].